After validating the efficiency of GAA A-GOs in enhancing FXN mRNA expression in FRDA cell models carrying 330/380 and 294/405 GAA⋅TTC repeats, we hypothesized that A-GOs should similarly function in cell models with a higher number of GAA⋅TTC repeats. This evidence concerns the gene FXN and Friedreich ataxia.